Federal Register #FMCSA-2013-0107, FMCSA-2013-0108, FMCSA-2015-0119, FMCSA-2017-0254, FMCSA-2018-0052, FMCSA-2022-0046, FMCSA-2023-0036, FMCSA-2023-0038

FMCSA Renewal of Exemptions for Drivers with Epilepsy or Seizure Disorders

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation, has issued a notice regarding the renewal of exemptions for commercial motor vehicle (CMV) drivers with epilepsy or seizure disorders. - Government Buyer: - Department of Transportation, Federal Motor Carrier Safety Administration (FMCSA), Medical Programs Division - Products/Services Requested: - Renewal of exemptions for 16 individuals with epilepsy or seizure disorders to operate CMVs in interstate commerce - No products, equipment, or commercial services are being procured - Unique or Notable Requirements: - Exemptions are contingent on strict medical monitoring, including annual medical examinations and ongoing reporting - Drivers must remain seizure-free and maintain stable treatment regimens - Exemptions are valid for a two-year period, with individual expiration dates - OEMs and Vendors: - No Original Equipment Manufacturers (OEMs) or vendors are involved, as this is not a procurement action - Places of Performance: - Exemptions apply to drivers residing in multiple states, including Massachusetts, Kansas, North Carolina, Pennsylvania, Mississippi, South Dakota, Maine, Iowa, Minnesota, Ohio, Kentucky, Maryland, Missouri, and Virginia - FMCSA headquarters serves as the federal office overseeing the exemptions

Description

The Federal Motor Carrier Safety Administration (FMCSA) announces its decision to renew exemptions for 16 individuals from the Federal Motor Carrier Safety Regulations that prohibit interstate commercial motor vehicle drivers from having epilepsy or seizure disorders. These exemptions allow individuals who have had seizures and are on anti-seizure medication to continue operating commercial motor vehicles in interstate commerce. The exemptions are granted for a two-year period with specific conditions including medical monitoring and reporting requirements. No public comments were received opposing the renewals.

View original listing